{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:45:02Z","timestamp":1790959502395,"version":"4.1.0"},"reference-count":31,"publisher":"Impact Journals, LLC","issue":"40","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,12,15]]},"DOI":"10.18632\/oncotarget.6466","type":"journal-article","created":{"date-parts":[[2015,12,5]],"date-time":"2015-12-05T04:50:44Z","timestamp":1449291044000},"page":"42530-42540","source":"Crossref","is-referenced-by-count":77,"title":["Oleoylethanolamide, an endogenous PPAR-\u03b1 ligand, attenuates liver fibrosis targeting hepatic stellate cells"],"prefix":"10.18632","volume":"6","author":[{"given":"Ling","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, Medical College, Xiamen University, Xiamen, Fujian, China"},{"name":"Clinical Research Institute, The First Affiliated Hospital, University of South China, Hengyang, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Medical College, Xiamen University, Xiamen, Fujian, China"},{"name":"Xiamen Diabetes Institute, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junde","family":"Chen","sequence":"additional","affiliation":[{"name":"Marine Biological Resource Comprehensive Utilization Engineering Research Center of the State Oceanic Administration, The Third Institute of Oceanography of the State Oceanic Administration, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Medical College, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Zheng","sequence":"additional","affiliation":[{"name":"College of Arts and Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Medical College, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Medical College, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,12,4]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Friedman","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.18632\/oncotarget.170","article-title":"Mouse models of hepatocarcinogenesis: what can we learn for the prevention of human hepatocellular carcinoma?","volume":"1","author":"Luedde","year":"2010","journal-title":"Oncotarget"},{"key":"3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"4","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Ramalingam","year":"2012","journal-title":"Nat Med"},{"key":"5","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/hep.23123","article-title":"Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies","volume":"50","author":"Schuppan","year":"2009","journal-title":"Hepatology"},{"key":"6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nrendo.2010.89","article-title":"PPARalpha: an emerging therapeutic target in diabetic microvascular damage","volume":"6","author":"Taskinen","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(09)61040-0","article-title":"PPAR-alpha and PPAR-gamma agonists for type 2 diabetes","volume":"374","author":"Charbonnel","year":"2009","journal-title":"Lancet"},{"key":"8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI27989","article-title":"Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis","volume":"116","author":"Staels","year":"2006","journal-title":"J Clin Invest"},{"key":"9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/ncpcardio1278","article-title":"Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease","volume":"5","author":"Zambon","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.dld.2007.10.002","article-title":"A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease","volume":"40","author":"Solis-Herruzo","year":"2008","journal-title":"Dig Liver Dis"},{"key":"11","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/hep.20170","article-title":"Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice","volume":"39","author":"Leclercq","year":"2004","journal-title":"Hepatology"},{"key":"12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbrc.2004.09.110","article-title":"PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats","volume":"324","author":"Okanoue","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jhep.2011.12.008","article-title":"PPARalpha activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats","volume":"56","author":"Garcia-Pagan","year":"2012","journal-title":"J Hepatol"},{"key":"14","first-page":"720","article-title":"Molecular Mechanism of PPARalpha Action and its Impact on Lipid Metabolism, Inflammation and Fibrosis in Non-Alcoholic Fatty Liver Disease","volume":"62","author":"Staels","year":"2014","journal-title":"J Hepatol"},{"key":"15","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.neuropharm.2005.02.013","article-title":"Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats","volume":"48","author":"Piomelli","year":"2005","journal-title":"Neuropharmacology"},{"key":"16","doi-asserted-by":"crossref","first-page":"e85337","DOI":"10.1371\/journal.pone.0085337","article-title":"Atheroprotective effect of oleoylethanolamide (OEA) targeting oxidized LDL","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"},{"key":"17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha","volume":"425","author":"Piomelli","year":"2003","journal-title":"Nature"},{"key":"18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1113\/jphysiol.2004.081844","article-title":"Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1","volume":"564","author":"Ahern","year":"2005","journal-title":"J Physiol"},{"key":"19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","article-title":"Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents","volume":"3","author":"Reynet","year":"2006","journal-title":"Cell Metab"},{"key":"20","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","article-title":"Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies","volume":"46","author":"Roeb","year":"2007","journal-title":"J Hepatol"},{"key":"21","first-page":"12","article-title":"Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice","author":"Di","year":"2013","journal-title":"Lipids Health Dis"},{"key":"22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.ki.5002243","article-title":"Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells","volume":"72","author":"Border","year":"2007","journal-title":"Kidney Int"},{"key":"23","doi-asserted-by":"publisher","first-page":"5700","DOI":"10.18632\/oncotarget.2144","article-title":"Loss of PPM1A expression enhances invasion and the epithelial-to-mesenchymal transition in bladder cancer by activating the TGF-\u03b2\/Smad signaling pathway","volume":"5","author":"Liu","year":"2014","journal-title":"Oncotarget"},{"key":"24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.joca.2006.10.009","article-title":"Agonists of peroxisome proliferators-activated receptors (PPAR) \u03b1, \u03b2\/\u03b4 or \u03b3 reduce transforming growth factor (TGF)-\u03b2-induced proteoglycans' production in chondrocytes","volume":"15","author":"Jouzeau","year":"2007","journal-title":"Osteoarthritis and cartilage"},{"key":"25","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.cellsig.2013.01.021","article-title":"Activation of PPAR-\u03b1 induces cell cycle arrest and inhibits transforming growth factor-\u03b21 induction of smooth muscle cell phenotype in 10T1\/2 mesenchymal cells","volume":"25","author":"Chiu","year":"2013","journal-title":"Cellular signalling"},{"key":"26","first-page":"e35","article-title":"PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4","volume":"91","author":"Law","year":"2002","journal-title":"Circ Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2006.03.044","article-title":"PPM1A functions as a Smad phosphatase to terminate TGF\u03b2 signaling","volume":"125","author":"Brunicardi","year":"2006","journal-title":"Cell"},{"key":"28","doi-asserted-by":"crossref","first-page":"H1443","DOI":"10.1152\/ajpheart.01056.2006","article-title":"Inhibition of PPAR-alpha activity in mice with cardiac-restricted expression of tumor necrosis factor: potential role of TGF-beta\/Smad3","volume":"292","author":"Barger","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"29","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.bbalip.2009.03.014","article-title":"Oleoylethanolamide, a natural ligand for PPAR-alpha, inhibits insulin receptor signalling in HTC rat hepatoma cells","volume":"1791","author":"Sanchez-Margalet","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/abio.2000.4509","article-title":"Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry","volume":"280","author":"Piomelli","year":"2000","journal-title":"Anal Biochem"},{"key":"31","doi-asserted-by":"publisher","first-page":"8330","DOI":"10.18632\/oncotarget.2212","article-title":"Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-\u03baB signaling pathway","volume":"5","author":"Sung","year":"2014","journal-title":"Oncotarget"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T18:29:25Z","timestamp":1589394565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,4]]},"references-count":31,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2015,12,15]]}},"alternative-id":["6466","26729705"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6466","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,4]]}}}